{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:32:33Z","timestamp":1771540353405,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate baseline features and morphologic changes of vitreoretinal adhesion and outer retinal layers outside the macula after intravitreal ocriplasmin injection. To study the relation between vitreous detachment and attenuation of retinal outer segments signal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective cases series of 15 eyes. Each eye was scanned with the 55\u00b0 wide-field optical coherence tomography lens in 6 different locations, three horizontal B-scan (central, temporal, and nasal) and three vertical B-scan (central, superior, and inferior) at baseline, 1 week, 1 month, 3 months, and 6 months after injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>After ocriplasmin injection, vitreomacular traction (VMT) resolved in 12 patients (80%), 3 of them presenting a complete posterior vitreous detachment. Eight patients (53%) showed a panretinal attenuation of photoreceptors outer segment signal, 7 with VMT resolution and 1 with non-posterior vitreous detachment and no VMT resolution. In three patients after VMT resolution the attenuation involved also areas with no posterior vitreous detachment. The attenuation resolved during follow-up in 7\/8 eyes (87.5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intravitreal ocriplasmin injection induced resolution of VMT in most cases and more rarely a release of vitreopapillary adhesion and a complete posterior vitreous detachment. An acute panretinopathy was visible in more than half of the patients and was not related to vitreous detachment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000001785","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T21:50:26Z","timestamp":1501710626000},"page":"1541-1548","source":"Crossref","is-referenced-by-count":8,"title":["OCRIPLASMIN FOR VITREOMACULAR TRACTION: LOOKING OUTSIDE THE MACULA"],"prefix":"10.1097","volume":"38","author":[{"given":"Matteo G.","family":"Cereda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Preziosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Bottoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Staurenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bjo.2009.157313","article-title":"Vitreous: the resplendent enigma","volume":"93","author":"Sebag","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archopht.119.10.1475","article-title":"Initial stages of posterior vitreous detachement in healthy eyes of older person evaluated by optical coherence tomography","volume":"119","author":"Uchino","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1097\/IAE.0b013e31825bef62","article-title":"Posterior vitreous detachment: evolution and role in macular disease","volume":"32","author":"Johnson","year":"2012","journal-title":"Retina"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00417-004-0980-1","article-title":"Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease","volume":"242","author":"Sebang","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajo.2009.11.022","article-title":"Posterior vitreous detachment: evolution and complication of its early stages","volume":"149","author":"Johnson","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1097\/IAE.0b013e3182993ef8","article-title":"OCT-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis","volume":"33","author":"Stalmans","year":"2012","journal-title":"Retina"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1097\/IAE.0b013e31825bc593","article-title":"Ocriplasmin for pharmacologic vitreolysis","volume":"32","author":"Kuppermann","year":"2012","journal-title":"Retina"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s40265-013-0124-1","article-title":"Ocriplasmin: a review of its use in patients with symptomatic vitreomacular adhesion","volume":"73","author":"Syed","year":"2013","journal-title":"Drugs"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"N Engl J Med"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaophthalmol.2014.278","article-title":"Safety and complication of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe are thou?","volume":"132","author":"Kim","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/IAE.0000000000000519","article-title":"Safety profile of Ocriplasmin for symptomatic vitreomacular adhesion","volume":"35","author":"Hahn","year":"2015","journal-title":"Retina"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/IAE.0000000000000448","article-title":"Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion\/traction","volume":"35","author":"Kaiser","year":"2015","journal-title":"Retina"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/IAE.0000000000000519","article-title":"Safety profile of ocriplasmin for vitreomacular adhesion: a comprehensive analysis of pre- and post-marketing experiences","volume":"35","author":"Hahn","year":"2015","journal-title":"Retina"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1097\/IAE.0000000000000667","article-title":"Acute ocriplasmin retinopathy","volume":"35","author":"Johnson","year":"2015","journal-title":"Retina"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/aos.12749","article-title":"Early panretinal abnormalities on fundus autofluorescence and spectral domain optical coherence tomography after intravitreal ocriplasmin","volume":"94","author":"Barteselli","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/bjophthalmol-2015-307480","article-title":"Wide field of view swept-source optical coherence tomography for peripheral retinal disease","volume":"100","author":"McNabb","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ajo.2009.11.016","article-title":"Observations by spectral-domain optical coherence tomography combined with simultaneous scanning laser ophthalmoscopy: imaging of the vitreous","volume":"149","author":"Mojana","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","article-title":"Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome","volume":"98","author":"Singh","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00417-015-3031-1","article-title":"Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study","volume":"254","author":"Chatziralli","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/23258160-20130715-05","article-title":"Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion","volume":"44","author":"Kim","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3109\/02713680903308487","article-title":"Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy","volume":"34","author":"Chen","year":"2009","journal-title":"Curr Eye Res"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamaophthalmol.2013.8142","article-title":"Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection","volume":"132","author":"Fahim","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R24-20230816","first-page":"6521304","article-title":"Comparison of guided and unguided Ocriplasmin injection for the treatment of vitreo macular traction: a preliminary study","volume":"2016","author":"Mastropasqua","year":"2016","journal-title":"J Ophtahlmol"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ophtha.2016.04.045","article-title":"Early optical coherence tomography findings after vitreomacular traction release","volume":"123","author":"Rahimy","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201808000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:21:33Z","timestamp":1692231693000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201808000-00012"}},"subtitle":["A Wide-Field Optical Coherence Tomography Study"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001785","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}